Oppenheimer & Co’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $272K | Sell |
3,250
-3
| -0.1% | -$251 | ﹤0.01% | 1396 |
|
|
2025
Q1 | $232K | Buy |
+3,253
| New | +$232K | ﹤0.01% | 1391 |
|
|
2022
Q3 | – | Sell |
-6,537
| Closed | -$18K | – | 1456 |
|
|
2022
Q2 | $18K | Sell |
6,537
-8,934
| -58% | -$24.6K | ﹤0.01% | 1390 |
|
|
2022
Q1 | $52K | Sell |
15,471
-4,587
| -23% | -$15.4K | ﹤0.01% | 1436 |
|
|
2021
Q4 | $123K | Sell |
20,058
-22,551
| -53% | -$138K | ﹤0.01% | 1433 |
|
|
2021
Q3 | $591K | Buy |
42,609
+371
| +0.9% | +$5.15K | 0.01% | 951 |
|
|
2021
Q2 | $722K | Buy |
42,238
+27,937
| +195% | +$478K | 0.01% | 872 |
|
|
2021
Q1 | $270K | Buy |
14,301
+10,256
| +254% | +$194K | 0.01% | 1227 |
|
|
2020
Q4 | $117K | Buy |
4,045
+30
| +0.7% | +$868 | ﹤0.01% | 1301 |
|
|
2020
Q3 | $151K | Sell |
4,015
-73
| -2% | -$2.75K | ﹤0.01% | 1197 |
|
|
2020
Q2 | $136K | Buy |
4,088
+67
| +2% | +$2.23K | ﹤0.01% | 1172 |
|
|
2020
Q1 | $144K | Buy |
+4,021
| New | +$144K | ﹤0.01% | 1079 |
|